Harnessing nanomedicine for mucosal theranostics -A silver bullet at last?

Eran Elinav; Dan Peer

doi:10.1021/nn400885b

Harnessing nanomedicine for mucosal theranostics -A silver bullet at last?

Eran Elinav, Dan Peer

Weizmann Institute of Science, Tel Aviv University

Research output: Contribution to journal › Review article › peer-review

Abstract

Inflammatory bowel disease (IBD) has been extensively studied in the last four decades both in animal models and humans. The treatment options remain disappointing, nonspecific, and associated with multiple systemic adverse effects. In this Perspective, we highlight issues related to emerging nanotechnologies designed particularly for treatment and disease management of IBD and discuss potential therapeutic target options with novel molecular imaging modalities.

Original language	English
Pages (from-to)	2883-2890
Number of pages	8
Journal	ACS Nano
Volume	7
Issue number	4
DOIs	https://doi.org/10.1021/nn400885b
State	Published - 23 Apr 2013

All Science Journal Classification (ASJC) codes

General Engineering
General Materials Science
General Physics and Astronomy

Access to Document

10.1021/nn400885b

Cite this

@article{bfb48cf0c50745d4b2a287dcba11edbc,

title = "Harnessing nanomedicine for mucosal theranostics -A silver bullet at last?",

abstract = "Inflammatory bowel disease (IBD) has been extensively studied in the last four decades both in animal models and humans. The treatment options remain disappointing, nonspecific, and associated with multiple systemic adverse effects. In this Perspective, we highlight issues related to emerging nanotechnologies designed particularly for treatment and disease management of IBD and discuss potential therapeutic target options with novel molecular imaging modalities.",

author = "Eran Elinav and Dan Peer",

year = "2013",

month = apr,

day = "23",

doi = "10.1021/nn400885b",

language = "الإنجليزيّة",

volume = "7",

pages = "2883--2890",

journal = "ACS Nano",

issn = "1936-0851",